Colin Goddard

Colin Goddard has filed trades across 3 companies (mainly through SEC (Form 4)), most often in OSI Pharmaceuticals Inc, Endocyte Inc and Human Genome Sciences Inc. The record holds 93 filings, for trades running from 2 June 2006 to 21 December 2018.

In open-market terms, that means 2 purchases worth €87k on one side and 61 sales worth €5.2M on the other. The net balance comes to €5.1M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 19 share grants and 4 option exercises.

The record was last updated on 21 December 2018 with a transaction (€163k) in Endocyte Inc. The clock since the last published purchase (5 August 2011) now reads 5,559 days. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.